Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal.
about
Plasmodium falciparum parasitaemia and malaria among pregnant women at first clinic visit in the mount Cameroon AreaA malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparumCytophilic antibodies to Plasmodium falciparum glutamate rich protein are associated with malaria protection in an area of holoendemic transmissionFc γ receptor IIIB (FcγRIIIB) polymorphisms are associated with clinical malaria in Ghanaian children.Human recombinant antibodies against Plasmodium falciparum merozoite surface protein 3 cloned from peripheral blood leukocytes of individuals with immunity to malaria demonstrate antiparasitic properties.T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals.Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adultsImpact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: part III: placental malaria, maternal health, and public health.Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe childrenThe quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malariaFunctional memory B cells and long-lived plasma cells are generated after a single Plasmodium chabaudi infection in mice.Plasmodium falciparum merozoite surface protein 1 (MSP-1)-MSP-3 chimeric protein: immunogenicity determined with human-compatible adjuvants and induction of protective immune response.Malaria epidemiology in an area of stable transmission in tribal population of Jharkhand, IndiaDevelopment of fluorescent Plasmodium falciparum for in vitro growth inhibition assaysFamilial correlation of immunoglobulin G subclass responses to Plasmodium falciparum antigens in Burkina Faso.Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity.Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans.Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemicPhase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen.Plasmodium falciparum malaria in children aged 0-2 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP).Antibody-mediated and cellular immune responses induced in naive volunteers by vaccination with long synthetic peptides derived from the Plasmodium vivax circumsporozoite protein.Towards a blood-stage vaccine for malaria: are we following all the leads?Genetic polymorphism and amino acid sequence variation in Plasmodium falciparum GLURP R2 repeat region in Assam, India, at an interval of five yearsMalaria immunoepidemiology in low transmission: correlation of infecting genotype and immune response to domains of Plasmodium falciparum merozoite surface protein 3Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana.Exoerythrocytic malaria vaccine development: understanding host-parasite immunobiology underscores strategic success.Parasite Specific Antibody Increase Induced by an Episode of Acute P. falciparum Uncomplicated MalariaMechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites.Sero-epidemiological evaluation of Plasmodium falciparum malaria in SenegalThe immunological challenge to developing a vaccine to the blood stages of malaria parasites.Antibodies directed against merozoite surface protein-6 are induced by natural exposure to Plasmodium falciparum in a low transmission environment.Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich proImpact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: I: introduction to placental malariaStrain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine.Recent advances in recombinant protein-based malaria vaccines.Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West AfricaAcquired immune responses to three malaria vaccine candidates and their relationship to invasion inhibition in two populations naturally exposed to malaria.Malaria resistance genes are associated with the levels of IgG subclasses directed against Plasmodium falciparum blood-stage antigens in Burkina Faso.Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children.
P2860
Q24701743-70B0D9F2-222A-432A-A92F-57FB0E16D71CQ24814432-232FDA6D-133A-4B84-B7A8-5A7DF6ED105CQ24815535-889580CB-A2DA-44DB-A936-B990D7ABD448Q31104503-9EAA150E-F175-47D4-A893-2CBD783DD569Q33244194-E0B26489-2D3C-4D02-B88F-EDFC3008C80FQ33291869-6DE6A182-8A92-4169-9569-C78E6F086385Q33305467-F0D41892-6427-46BD-BD6A-614B595C6ED0Q33380213-34ADBBD1-94E1-45DC-9D6E-C427D3986E25Q33380234-82F71DAD-C3CF-4C5B-94FF-38E5686EFC38Q33512533-F7CC7A0B-7CD9-44FD-956C-A657F52E9288Q33512926-008F772B-BAF7-40E8-8F5E-EA3E3698AB90Q33518486-AA961635-DAE8-4E72-A332-A99E7E4ADBC9Q33613937-19C19D19-C7E1-46B3-9318-1BB03B591A50Q33629755-D7B5194A-04AA-4B35-9949-8135203FBAE1Q33939788-CA844EC9-F0E1-43D2-A0BB-F9290CEE0CDDQ34006021-7940B775-CCFC-4C28-A794-05583F2B64FBQ34008755-C2C58856-A595-4F12-BB39-5B6F7113812AQ34081745-E71CC8D4-0653-450A-A032-A8F37E650118Q34189972-58B748F7-D833-4CF0-BDA7-26E71D92DF81Q34194609-B5C38D81-B57C-415D-ACC6-C71512E61298Q34215916-63CDABED-E51C-4C2E-BFB3-C2242A0482D2Q34546220-AC2ED602-64B5-4DD4-B09F-BF796C4D007BQ34572160-B9849658-F49B-43BB-B5EB-6B08C24EAAFEQ34636542-BB8451CA-51D5-4CEC-9CED-C91DA3AA1AF3Q34931887-64E5B08E-C2DA-4799-A8E6-44988CED673DQ35003931-93F6E0E0-CF2C-43E1-814E-A15DDF6453FEQ35193463-028DAD12-DD73-4CCB-9EA1-BD9EBF56970AQ35532952-86DB1B59-365C-4EA1-9A22-2251C2504F48Q35606514-EC348F21-7285-4665-B1A3-2D9A11A69F43Q35853662-9B5F1FE7-49EB-4F78-889E-7F21F4090D81Q35884247-26E80C2C-1FE9-4D27-8C86-E59A1B80500CQ36002836-328332A9-8347-44B3-9C79-B363EFBF91D7Q36227049-C435E37E-8F82-495D-98A7-AFEC4E460AF5Q36274941-D90859E6-EC44-486F-AD57-3D29D0236859Q36304234-682B9155-A26F-408C-9593-CEB7C49D3221Q36394182-0FEF7FF9-B0F6-4A06-BBD2-756E77FB9116Q36421572-4642DAD7-6DE1-4F9D-8B65-C58F67DB4ADCQ36550447-20375FCD-C887-4BEA-A36C-6B45F1F28862Q36556078-61C5073F-3FE3-4473-9435-D739A2963B5BQ36862490-D51D6E62-CC28-4AEF-A556-EAAFA9E54B16
P2860
Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Cytophilic immunoglobulin resp ...... al malaria in Dielmo, Senegal.
@en
Cytophilic immunoglobulin resp ...... al malaria in Dielmo, Senegal.
@nl
type
label
Cytophilic immunoglobulin resp ...... al malaria in Dielmo, Senegal.
@en
Cytophilic immunoglobulin resp ...... al malaria in Dielmo, Senegal.
@nl
prefLabel
Cytophilic immunoglobulin resp ...... al malaria in Dielmo, Senegal.
@en
Cytophilic immunoglobulin resp ...... al malaria in Dielmo, Senegal.
@nl
P2093
P2860
P921
P1476
Cytophilic immunoglobulin resp ...... al malaria in Dielmo, Senegal.
@en
P2093
P2860
P304
P356
10.1128/IAI.68.5.2617-2620.2000
P407
P577
2000-05-01T00:00:00Z